Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2007 6
2008 5
2009 2
2010 7
2011 10
2012 19
2013 22
2014 17
2015 16
2016 22
2017 20
2018 24
2019 28
2020 19
2021 33
2022 24
2023 39
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.
Witkowski MT, Dolgalev I, Evensen NA, Ma C, Chambers T, Roberts KG, Sreeram S, Dai Y, Tikhonova AN, Lasry A, Qu C, Pei D, Cheng C, Robbins GA, Pierro J, Selvaraj S, Mezzano V, Daves M, Lupo PJ, Scheurer ME, Loomis CA, Mullighan CG, Chen W, Rabin KR, Tsirigos A, Carroll WL, Aifantis I. Witkowski MT, et al. Among authors: scheurer me. Cancer Cell. 2020 Jun 8;37(6):867-882.e12. doi: 10.1016/j.ccell.2020.04.015. Epub 2020 May 28. Cancer Cell. 2020. PMID: 32470390 Free PMC article.
Risk factors for childhood and adult primary brain tumors.
Ostrom QT, Adel Fahmideh M, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, Bondy ML. Ostrom QT, et al. Among authors: scheurer me. Neuro Oncol. 2019 Nov 4;21(11):1357-1375. doi: 10.1093/neuonc/noz123. Neuro Oncol. 2019. PMID: 31301133 Free PMC article. Review.
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group.
Martin-Giacalone BA, Richard MA, Scheurer ME, Khan J, Sok P, Shetty PB, Chanock SJ, Li SA, Yeager M, Marquez-Do DA, Barkauskas DA, Hall D, McEvoy MT, Brown AL, Sabo A, Scheet P, Huff CD, Skapek SX, Hawkins DS, Venkatramani R, Mirabello L, Lupo PJ. Martin-Giacalone BA, et al. Among authors: scheurer me. J Natl Cancer Inst. 2023 Jun 8;115(6):733-741. doi: 10.1093/jnci/djad055. J Natl Cancer Inst. 2023. PMID: 36951526 Free PMC article.
Cancer risk among RECQL4 heterozygotes.
Martin-Giacalone BA, Rideau TT, Scheurer ME, Lupo PJ, Wang LL. Martin-Giacalone BA, et al. Among authors: scheurer me. Cancer Genet. 2022 Apr;262-263:107-110. doi: 10.1016/j.cancergen.2022.02.001. Epub 2022 Feb 9. Cancer Genet. 2022. PMID: 35219053
Children's Oncology Group's 2023 blueprint for research: Epidemiology.
Lupo PJ, Marcotte EL, Scheurer ME, Poynter JN, Spector LG; COG Epidemiology Committee. Lupo PJ, et al. Among authors: scheurer me. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30566. doi: 10.1002/pbc.30566. Epub 2023 Jul 14. Pediatr Blood Cancer. 2023. PMID: 37449937
Sleep-wake disturbance in patients with brain tumors.
Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM. Armstrong TS, et al. Among authors: scheurer me. Neuro Oncol. 2017 Mar 1;19(3):323-335. doi: 10.1093/neuonc/now119. Neuro Oncol. 2017. PMID: 27286798 Free PMC article. Review.
Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcome.
Contreras Yametti GP, Evensen NA, Schloss JM, Aldebert C, Duan E, Zhang Y, Hu J, Chambers TM, Scheurer ME, Teachey DT, Rabin KR, Raetz EA, Aifantis I, Carroll WL, Witkowski MT. Contreras Yametti GP, et al. Among authors: scheurer me. Blood Adv. 2023 Aug 8;7(15):3928-3931. doi: 10.1182/bloodadvances.2023010044. Blood Adv. 2023. PMID: 37196626 Free PMC article.
Identification of USP9X as a leukemia susceptibility gene.
Sisoudiya SD, Mishra P, Li H, Schraw JM, Scheurer ME, Salvi S, Doddapaneni H, Muzny D, Mitchell D, Taylor O, Sabo A, Lupo PJ, Plon SE. Sisoudiya SD, et al. Among authors: scheurer me. Blood Adv. 2023 Aug 22;7(16):4563-4575. doi: 10.1182/bloodadvances.2023009814. Blood Adv. 2023. PMID: 37289514 Free PMC article.
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis.
El-Serag H, Kanwal F, Ning J, Powell H, Khaderi S, Singal AG, Asrani S, Marrero JA, Amos CI, Thrift AP, Luster M, Alsarraj A, Olivares L, Skapura D, Deng J, Salem E, Najjar O, Yu X, Duong H, Scheurer ME, Ballantyne CM, Kaochar S. El-Serag H, et al. Among authors: scheurer me. Gut. 2024 Feb 16:gutjnl-2024-332034. doi: 10.1136/gutjnl-2024-332034. Online ahead of print. Gut. 2024. PMID: 38365278
283 results